News
[PUBLICATION] The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder.
Dates
from February 27, 2024 to March 26, 2024
A publication by Mathieu Fonteneau, Jerôme Becker and Julie Le Merrer in Neuropharmacology, in collaboration with the USA.